Biological Fe(II) oxidation by iron-oxidising bacteria (FeOBs) at low pH is a cost-effective treatment for acid mine drainage (AMD). However, treatments based on this process are limited because of uncertainties regarding the ability and rate of oxidation of Fe(II) from AMD. In the present study, an indigenous FeOBs consortium was enriched in AMD, and its ability to oxidise Fe(II) is described. The bio-oxidation rate of Fe(II) was 39.1 mg/(L·h) under optimal culture conditions [35 ℃, pH 2.0, 500 mg/L Fe(II)]. In addition, the oxidation rate equation of Fe(II) could be fitted to a zero-order kinetic model, indicating that Fe(II) was oxidised at a constant rate. Furthermore, a continuous-flow bioreactor was developed to simulate the Fe(II) oxidation efficiency of indigenous FeOBs for in situ AMD biological treatment. The maximum Fe(II) oxidation rate was 22.8 mg/(L·h) when the influent Fe(II) load was 32.3 mg/(L·h). Acidithiobacillus and Acidiphilium were the dominant species contributing to Fe(II) oxidation in the bioreactor, accounting for 67.7 % and 32.8 %, respectively. The results will help promote the application of FeOBs in AMD treatment.